NASDAQ: VINC
Vincerx Pharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VINC stock forecasts and price targets.

Forecast return on equity

Is VINC forecast to generate an efficient return?

Company
N/A
Industry
145.91%
Market
81.63%

Forecast return on assets

Is VINC forecast to generate an efficient return on assets?

Company
N/A
Industry
35.93%

VINC earnings per share forecast

What is VINC's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$6.40

VINC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VINC$0.10N/AN/A
ONCO$0.06N/AN/A
GRI$1.45$11.50+693.10%Buy
SPRC$0.28N/AN/A
APVO$0.69N/AN/A

Vincerx Pharma Stock Forecast FAQ

What is VINC's earnings growth forecast for 2025-2025?

(NASDAQ: VINC) Vincerx Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.12%.

Vincerx Pharma's earnings in 2025 is -$30,074,000.

In 2025, VINC is forecast to generate -$33,499,373 in earnings, with the lowest earnings forecast at -$33,499,373 and the highest earnings forecast at -$33,499,373.

If you're new to stock investing, here's how to buy Vincerx Pharma stock.

What is VINC's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: VINC) forecast ROE is N/A, which is considered weak.

What is VINC's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: VINC) Vincerx Pharma's current Earnings Per Share (EPS) is -$15.85. In 2025, VINC's EPS is forecast to hit -$6.40 (min: -$6.40, max: -$6.40).

What is VINC's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: VINC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 35.93%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.